#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain injury Hypotransferrinaemia Shprintzen-Goldberg syndrome Acute graft versus host disease in skin Adult T-cell lymphoma/leukaemia refractory Sexually transmitted disease Aspergillus infection Chronic graft versus host disease Vitamin B12 deficiency Nodal marginal zone B-cell lymphoma Henoch-Schonlein purpura Atopic keratoconjunctivitis Osteosarcoma metastatic Congenital cystic kidney disease Congenital absence of bile ducts More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Cystic fibrosis lung – Diagnostics Antithrombin III deficiency – Treatment Angiosarcoma – Basic Information Ocular melanoma – Life with Disease Adrenogenital syndrome Angelman’s syndrome – Basic Information Familial haemophagocytic lymphohistiocytosis – Treatment Pleural mesothelioma malignant – Basic Information Synovial sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thiopental Sodium PARECOXIB GEN1078 Dexamethasone Base GS-1720 Glucose, Anhydrous Eptacog Beta (Activated) Hhalpc Metoprolol Dipyridamole Sar441566 Dornase Alfa Metoprolol Tartrate Cldn6 Car-T Olaptesed Pegol NADOFARAGENE FIRADENOVEC Amphotericin B Rimegepant Cx-037231 Diazepam More therapies…

    Learn about Your Condition

    Erythema Endometrial cancer metastatic Ectopic pregnancy Rubella Colorectal adenocarcinoma Round cell liposarcoma Pancreatic fistula SAPHO syndrome Intestinal obstruction Medulloblastoma recurrent Von Willebrand's disease Erythema migrans Biliary adenoma Primary adrenal insufficiency Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Title: Comparison of Oral Esketamine versus Electroconvulsive Therapy in Patients with Treatment-Resistant Depression

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Esketamine
    The Netherlands

  • Study on Cannabidiol as an Add-On Treatment for Patients with Early Schizophrenia

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Cannabidiol
    Germany

  • Study on Improving Social Skills in Schizophrenia Using Oxytocin or Placebo as an Add-On Treatment for Patients with Schizophrenia Spectrum Disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Schizophrenia
    • Psychotic disorder
    Investigated Drugs:
    • Oxytocin
    Germany

  • Study on Psilocybin for Treating Depression in Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Psilocybine
    • (4R)-1-[(3-(11C)Methylpyridin-4-Yl)Methyl]-4-(3,4,5-Trifluorophenyl)Pyrrolidin-2-One
    Sweden

  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    • Major depression
    • Schizophrenia
    Investigated Drugs:
    • Escitalopram
    • Esketamine Hydrochloride
    • Lithium
    Austria Germany Italy Spain

  • Study on the Effects of Ketamine and Electroconvulsive Therapy in Patients with Treatment-Resistant Major Depressive Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    Italy
Previous Page
1 … 26 27 28 29 30 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!